Aplasia cutis congenita associated with fetus papyraceous.
This report describes a healthy infant born with an isolated, truncal cutis aplasia defect in association with a fetus papyraceous. Effective healing of the cutaneous defect occurred over the course of a month. A 2-year follow-up demonstrate stable wound coverage. This rare association of aplasia cutis congenita, with a fetus papyraceous points most likely to the vascular causation of the cutaneous defect.
Classen
D A
DA
Department of Surgery, University of Saskatchewan, Royal University Hospital, Saskatoon, Canada.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001414:Bacitracin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004200:Diseases in Twins / Q000175:diagnosis*; D004476:Ectodermal Dysplasia / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005313:Fetal Death; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011112:Polymyxin B / Q000627:therapeutic use; D011247:Pregnancy; D013909:Thorax; D014427:Twins
D000900:Anti-Bacterial Agents; D001414:Bacitracin; D011112:Polymyxin B